Abstract
Several drugs are able to influence hair growth, resulting in hair loss (effluvium) or hypertrichosis. Clinical symptoms are the result of interactions between the drug and various cells important for hair growth, such as follicular keratinocytes, cells of the matrix, and those of connective tissue surrounding the bulb and perifollicular blood vessels. Especially the keratinocytes of the hair follicle are a major target for toxic effects by environmental agents or xenobiotics. One reason for this is that up to 90% of all hair follicles are in a phase of rapid growth, and the high blood flow rate around hair bulbs results in a good bioavailability of many compounds (Orfanos et al. 1976; Zaun 1986). Another reason may be that follicular keratinocytes are capable of much more enzymatic activity in metabolizing exogenous compounds than are other keratinocytes (Wattenberg and Leong 1970). This has been shown by the assessment of enzyme-dependent activities, by histochemical analysis and by immunofluorescent staining with monoclonal antibodies that react with cytochrome P-450 isoenzymes (Merk et al. 1984; Wattenberg and Leong 1970).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bendtzen K (1984) Ciclosporin (Cyclosporin A): prototype of a new generation of immune suppressive drugs. Allergy 39:565–571
Blankenship ML (1983) Drugs and alopecia. Aust J Dermatol 24:100–104
Boyd MR, Grygiel JJ, Miuchin RF (1983) Metabolic activation as a basis for organ selective toxicity. Clin Exp Pharmacol Physiol 10:87–99
Braun-Falco O (1961) Klinik und Pathomechanismus der Endoxan-Alopecie als Beitrag zumv Wesen cytostatischer Alopecien. Arch Klin Exp Dermatol 212:194–216
Burton JL, Schutt WH, Caldwell IW (1975) Hypertrichosis due to diazoxide. Br J Dermatol 93:707–711
Chytil F, Ong DE (1979) Cellular retinol- and retinoic acid-binding proteins in vitamin A action. Fed Proc 38:2510–2514
Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB (1984) Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 10:667–682
Crounse RG, van Scott EJ (1960) Changes in scalp hair roots as a measure of toxicity from cancer chemotherapeutic drugs. J Invest Dermatol 35:83–90
De Luca LM, Bhat PV, Sosak W, Adams S (1979) Biosynthesis of phosphoryl and glycosyl phosphoryl derivatives of vitamin A in biological membranes. Fed Proc 38:2535–2539
Fiedler-Weiss VC, West DP, Buys CM, Rumsfield JA (1986) Topical minoxidil dose-response effect in alopecia areata. Arch Dermatol 122:180–182
Franz TJ (1986) Percutaneous absorption of minoxidil in man. Arch Dermatol 121:203–206
Gerstein E, Orfanos CE (1976) Haarausfall nach Zytostatika. Ärztl Kosmetol 6:54–60
Gollnick H, Schwarztkopf W, Pröschle W, Luley C, Schleising M, Mattheis E, Orfanos CE (1985) Retinoids and blood lipids: an update and review. In: Saurat JH (ed) Retinoids. Karger, Basel
Hammond PB, Beliles RP (1980) Metals. In: Doull CJ, Klaassen CD, Amdur MO (eds) Toxicology. Macmillan, New York
Headington JT, Novak E (1984) Clinical and histological studies of male pattern baldness treated with topical minoxidil. Curr Ther Res Clin Exp 36:1098–1106
Hommes H (1983) Dacarbazin: Wirkungen auf Haarwurzeln, Blutbild und Leberenzyme. Thesis, University of Cologne
Kiser J, Jung E, Salchi S, Heckendorn V, Brunner KW (1983) Der zytostatikabedingte Haarausfall. Schweiz Rundsch Med Prax 72:1289–1292
Ippen H (1970) Haarausfall durch Medikamente. Dtsch Med Wochenschr 95:1411–1416
Levantine A, Almeyda J (1973) Drug induced alopecia. Br J Dermatol 89:549–553
Melnik B, Plewig G (1986) Retinoide und Lipidstoffwechsel. Hautarzt 37:304–311
Merk H, Rumpf M, Bolsen K, Wirth G, Goerz G (1984) Inducibility of arylhydrocarbon-hydroxylase activity in human hair follicles by topical application of liquor carbonis detergens (coal tar). Br J Dermatol 111:279–284
Merk H, Muhktar H, Kaufmann I, Das M, Bickers DR (1987) Human hair follicle carcinogen metabolism. J Invest Dermatol 88:71–76
Novak E, Franz TJ, Headington JT, Wester RC (1985) Topically applied minoxidil in baldness. Int J Dermatol 24:83–87
Olsen EA, Weiner MS, Delong ER, Pinnel SR (1985) Topical minoxidil in early male pattern baldness. J Am Acad Dermatol 13:185–192
Olsen EA, deLong ER, Weiner MS (1986) Dose response study of topical minoxidil in male pattern baldness. J Am Acad Dermatol 15:30–37
Orfanos CE, Gerstein E (1976) Haarausfall und Zytostatika. Ärztl Kosmet 6:96–105
Orfanos CE, Gerstein E, Runne U (1976) Der zytostatische Haarverlust als biologisches Modell. Dtsch Med Wochenschr 101:1466–1468
Paus R, Stenn KS, Link RE (1989) The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. Lab Invest 60:365–369
Reeves JRT, Maibach HI (1977) Drug and chemical induced hair loss. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology and pharmacology. Halsred, New York
Rook A, Dawber R (1982) Diseases of the hair and scalp. Blackwell, Oxford
Steigleder GK (1978) Haut. In: Heintz R (ed) Erkrankungen durch Arzneimittel. Thieme, Stuttgart
Steigleder GK, Mahrle G (1973) Haarausfall als polyätiologisches Symptom. Fortschr Prakt Dermatol Venerol 7:237–248
Sunderman FW (1967) Diethyldithiocarbamate therapy for thallotoxicosis. Am J Med Sci 253:209–220
Thomson AW, Whiting PH, Simpson JG (1984) Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions 15:306–327
Tuchman M, Stoeckeler JS, Kiang DT, O’Dea ML, Ramnarine ML, Mirkin BL (1985) Familial pyrimidinemia and pyrimidinura associated with severe fluorouracil toxicity. N Engl J Med 313:245–249
Vanderveen EE, Ellis CN, Kang S, Case P, Headington JT, Voorhees J, Swanson NA (1984) Topical minoxidil for hair regrowth. J Am Acad Dermatol 11:416–421
Vesell ES (1979) Pharmacogenetics: multiple interactions between genes and environment as determinants of drug response. Am J Med 66:183–187
Vesell ES (1984) Pharmacogenetic perspectives: genes, drugs, and disease. Hepatology 4:959–965
Vesell ES, Penno MB (1983) Assessment of methods to identify sources of interindividual pharmacokinetic variations. Clin Pharmacokinet 8:378–409
Vestey ES, Savin JA (1986) A trial of 1% minoxidil used topically for severe alopecia areata. Acta Derm Venereol (Stockh) 66:179–180
Wattenberg W, Leong JC (1970) Benzpyrene hydroxylase in mouse skin. Proc Am Assoc Cancer Res 11:81
Weiss VC, West DP (1985) Topical minoxidil therapy and hair regrowth. Arch Dermatol 121:191–192
White SI, Friedmann PS (1985) Topical minoxidil lacks efficacy in alopecia areata. Arch Dermatol 121:591
Zaun H (1986) Haarkrankheiten — Systematik, pathophysiologische Grundlagen, Differentialdiagnose. Therapiewoche 36:2695–2700
Zaun H, Neumann K, Werner G (1972) Die Feinstruktur dystrophischer Haare bei Vitamin A- und Thallium-Intoxikation. Hautarzt 23:544–550
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Merk, H.F. (1990). Drugs Affecting Hair Growth. In: Orfanos, C.E., Happle, R. (eds) Hair and Hair Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74612-3_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-74612-3_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74614-7
Online ISBN: 978-3-642-74612-3
eBook Packages: Springer Book Archive